Exam Flashcards
Acetyl-salicylic acid
A. Anti-platelet/ NSAID
B. Inhibits synthesis of prostaglandin by cyclooxygenase; inhibits platelet aggregation; has antipyretic and analgesic activity
C. ACS, osteoarthirits
Acyclovir
A. Anti-viral
B. Interferes with DNA polymerase to inhibit DNA replication via chain termination
C. Genital herpes
Adrenaline (Epinephrine)
A. Catecholamine
B. Strong alpha-adrenergic effects, which cause an increase in cardio output and HR, a decrease in renal perfusion and PVR, and a variable effect on BP, resulting in systemic vasoconstriction and increased vascular permeability
C. Cardiac arrest, asthma.
Alendronate
A. Bisphosphate derivative
B. Bisphosphonate; binds to hydroxyapatite crystals in bone and inhibits osteoclast-mediated bone resorption; decreases mineral release and collagen or matrix breakdown in bone
C. Osteoporsis
Aminophylline
A. Xanthine derivative/ phospho-diesterase enzyme inhibitor.
B. Methylxanthine; directly relaxes smooth muscles of respiratory tract
C. Acute bronchospasm
Amiodarone
A. Anti-arrhythmic (class 3) B. Inhibits adrenergic stimulation; affects potassium channels. Markedly prolongs action potential and repolarization; decreases AV conduction and sinus node function C. V-tach/ V-Fib
Amoxicillin/ Clauvanic acid (co-amoxiclav)
A. Penicillin (Bactericidal)
B. Binds to penicillin-binding proteins, thus inhibiting peptidoglycan synthesis in bacterial cell walls; addition of clavulanate inhibits beta-lactamase-producing bacteria. Against both Gr +/-
C. Lower respiratory tract infection/ acute sinusitis
Aripiprazole
A. Anti-pyschotic (2nd gen)/ Atypical
B. Partial agonist at dopamine D2 and serotonin type 1 (5-HT1A) receptors. Antagonist at serotonin type 2 (5-HT2A) receptor.
C. Schizophrenia/ Bipolar disorder
Amitriptyline
A. Antidepressant (TCA)
B. Inhibits re-uptake of serotonin thereby increasing its concentration in the synapse.
C. Depression
Amlodipine
A. Calcium channel blocker.
B. Inhibits transmembrane influx of extracellular calcium ions across membranes of myocardial cells and vascular smooth muscle cells this inhibits cardiac and vascular smooth muscle contraction, thereby dilating main coronary and systemic arteries.
C. Hypertension/ CAD/ Angina
Atorvastatin
A. HmG-CoA reductase/ Statins
B. HMG-CoA reductase inhibitor; inhibits rate-limiting step in cholesterol biosynthesis by competitively inhibiting HMG-CoA reductase.
C. CAD prophylaxis
Atovaquone/Proguanil
A. anti-malarial
B. Atova… Selective inhibitor of parasite mitochondrial electron transport
Prog… reductase inhibitor in malaria parasite, which leads to disruption of deoxythymidylate synthesis
C. Malaria
Atropine
A. Anti-cholinergic (against parasympathetic system)
B. Anti-muscarinic; inhibits action of acetylcholine at parasympathetic sites in smooth muscle, CNS, and secretory glands. Increases cardiac output and dries secretions
C. Cycloplegia (paralyse ciliary muscle in eye)
Benzylpenicillin (Penicillin G)
A. Penicillin G (narrow spectrum)
B. Interferes with synthesis of cell wall mucopeptide during active multiplication, resulting in bactericidal activity against susceptible microorganisms.
C. Cellulitis/ infective endocarditis/ syphillis/ meningitis/ pneumonia/ septicaemia
Bevacizumab
A. Antineoplastic
B. Recombinant humanised monoclonal antibody to VEGF; blocks the angiogenic molecule VEGF thereby inhibiting tumour angiogenesis, starving tumour of blood and nutrients.
C. Metastatic colorectal cancer/ non-small cell lung cancer/ breast cancer
Bevacizumab (bare jokes option)
A. Anti-cancer
B. Stops cancer
C. Cancer
Keep going :) :)
You pharmacology stud ;)
Bisacodyl
A. Laxative
B. Irritates smooth muscle of intestine and possibly colonic intramural plexus, thus in turn increasing peristalsis
C. Helps you to poop/ constipation
Bisoprolol
A. Beta Blocker
B. Blocks response to beta-adrenergic stimulation; cardioselective for beta-1 at low doses with little or no effect on beta-2 receptors.
C.Hypertension/ heart failure
Bromazepam
A. Benzodiazepine
B. Binds to BZ receptors, increases concentration of GABA, GABA binds to GABA rec, increases chloride ion concentration, hyperpolarises membrane of CNS leading to sedation.
C Anti-anxiety/ anti-convulsant/ sedative
Bupivacaine
A. Local anaesthetic
B. Prevents generation of nerve impulses by reducing sodium permeability & increasing action potential threshold
C. Epidural block/ peripheral nerve block/
Carbamazepine
A. Anti-convulsant
B. Stabilises inactivated state of sodium channels, thereby making neurones less excitable
C. Epilepsy
Ceftriaxone
A. Cephalosporin (3rd gen)
B. Broad-spectrum gram-negative activity; has lower efficacy against gram-positive organisms but higher efficacy against resistant organisms; highly stable in presence of beta-lactamases (penicillinase and cephalosporinase) of gram-negative and gram-positive bacteria; bactericidal activity results from inhibiting cell-wall synthesis by binding to 1 or more penicillin-binding proteins; bacteria eventually lyse.
C. Lower abdominal infection/ Otitis media/ Septicaemia
Cephalexin
A. Cephalosporin (1st gen)
B. Effective for treatment of infections caused by streptococcal or staphylococci, including penicillinase-producing staphylococci. Bactericidal inhibits synthesis of peptidoglycan in cell walls, there by causing cell lysis.
C. Otitis media/ genito-urinary infection/ Bone infection
Ciprofloxacin
A. Flouroquinolones
B. Inhibits relaxation of DNA; inhibits DNA gyrase in susceptible organisms; promotes breakage of double-stranded DNA
C. Acute sinusitis/ Bone infections/ Diarrhoea
Clarithromycin
A. Macroglides
B. Semisynthetic macrolide antibiotic that reversibly binds to P site of 50S ribosomal subunit of susceptible organisms and may inhibit RNA-dependent protein synthesis thereby inhibiting bacterial growth
C. Chronic bronchitis/ Acute sinusitis
Clomiphene
A. Selective estrogen receptor modulator
B. Binds to estrogen receptors, induces ovulation by increase output of pituitary gonadotropins
C. Ovulatory induction
Clonidine
A. Centrally acting alpha 2 agonist
B. Binds to imidazoline receptors and stimulates alpha 2 receptors in the brain causes a decrease in peripheral vascular resistance which lowers blood pressure.
C. Hypertension
Clopidogrel
A. Anti-platelet
B. Inhibitor of adenosine diphosphate (ADP)-induced pathway for platelet aggregation
C. MI/ Angina/ Stroke
Clotrimazole
A. Anti-fungal
B. Alters Candida cell membrane permeability; binds to phospholipids in fungal cell membrane, which alters cell wall permeability and results in the loss of intracellular elements; fungistatic and fungicidal
C. Candidasis
Co-trimoxazole
A. Bactericidal antibiotic
B. Inhibits dihydrofolate reductase, which in turn inhibits folic acid reduction to tetrahydrofolate, causing inhibition of microorganism growth.
C. Bronchitis/ Otitis media/ Travellers diarrhoea/ HIV prophylaxis/ UTI
Dabigatran
A. Anti-coagulant
B. Prevents thrombus development through direct, competitive inhibition of thrombin (thrombin enables fibrinogen conversion to fibrin during the coagulation cascade)
C. Stroke prophylaxis/ DVT
Desmopressin (ADH)
A. ADH analogue
B. Synthetic analogue of vasopressin with prompt onset and longer, more specific antidiuretic action; desmopressin increases water permeability in renal tubular cells, which in turn decreases urine volume and increases urine osmolality
C. Diabetes insipidus
Dextromethorphan
A. Anti-tussive (anti-coughing)
B. Acts on cough center in medulla; decreases sensitivity of cough receptors and interrupts cough impulse transmission
C. Cough
Diazepam
A. Benzodiazepine
B. Modulates postsynaptic effects of GABA-A transmission, resulting in an increase in presynaptic inhibition. Appears to act on part of the limbic system, as well as on the thalamus and hypothalamus, to induce a calming effect
C. Anxiety/ Alcohol withdrawal syndrome
Diclofenac
A. NSAID
B. Inhibits cyclooxygenase (COX)-1 and COX-2, thereby inhibiting prostaglandin synthesis
C. Rheumatoid arthritis/ Osteoarthritis
Digoxin
A. Anti-arrhythmic class 5
B. Suppresses AV node conduction, which increases refractory period and decreases conduction velocity, causing positive inotropic effect, decreased ventricular rate, and enhanced vagal tone.
C.Atrial fibrillation/ Heart failure.
Diltiazem
A. Anti-arrhythmic class 4 B. Nondihydropyridine calcium-channel blocker: Inhibits extracellular calcium ion influx across membranes of myocardial cells and vascular smooth muscle cells, resulting in inhibition of cardiac and vascular smooth muscle contraction acting principally at AV node, with some effects at sinus node C. Angina/ A-fib/ A flut/ PSVT
Dinoprost
A. Prostaglandin F2alpha
B. Relaxes cervical smooth muscle; stimulates uterine contractions similar to those observed during labor
C. Labour induction (Note: can be used for abortion as wel)
Dobutamine
A. Inotropic agent.
B. Strong beta1 and weak beta2/alpha effects, resulting in increased cardiac output, blood pressure, and heart rate, as well as decreased peripheral vascular resistance
C. Heart failure/ Cardiogenic shock
Dopamine
A. Inotropic agent
B. Crosses blood brain barrier and increases dopamine concentration in the substantia nigra.
C. Parkinson
Doxazosin
A. Alpha blocker/ Anti-neoplastic
B. Benign prostatic hyperplasia (BPH): Blocks alpha1 receptors in prostatic stromal and bladder tissues; reduces sympathetic tone-induced urethral stricture responsible for BPH symptoms
C. Prostatic cancer
Doxorubicin
A. Antineoplastic
B. Anthracycline; intercalates between DNA base pairs, impairs topoisomerase II function and inhibits replication & transcription
C. Cancer/ Hepatocellular carcinoma
Doxycycline
A. Tetracycline (antibiotics)
B. Inhibits protein synthesis and, thus, bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria; may block dissociation of peptidyl t-RNA from ribosomes, causing RNA-dependent protein synthesis to arrest.
C. STI
Enoxaparin
A. Anticoagulant
B. LMWH; antithrombotic that inhibits factor Xa by increasing inhibition rate of clotting proteases that are activated by antithrombin III
C. DVT prophylaxis/ Angina/ STEMI
Ephedrine
A. Alpha/ Beta adrenergic agonist (lung drug bruv)
B. Sympathomimetic agent stimulates SNS and directly stimulates adrenergic receptor.
C. Decongestant/ Apetite suppression/ Anaesthetic associated hypotension
Escitalopram
A. Antidepressant SSRI
B. Inhibits the re-uptake of serotonin in the synapses thereby increasing serotonin concentration.
C. Major depressive disorder/ OCD
Etoricoxib
A. NSAID
B. Selective COX-2 inhibitor
C. Rheumatoid arthritis/ osteoarthritis/ ankylosing spondylitis/ Gout
Ezetimibe
A. Lipid lowering agent
B. Inhibits sterol transporter at brush border and, consequently, intestinal absorption of cholesterol, which in turn decreases delivery of cholesterol to the liver and reduces hepatic cholesterol stores.
C. Hyper-cholesterolemia
Finasteride
A. Antineoplastic/ 5 Alpha reductase inhibitor
B. Suppresses serum dihydrotestosterone levels by inhibiting the conversion of testosterone to dihydrotestosterone
C. Benign prostatic hyperplasia
Fluconazole
A. Anti-fungal
B. Highly selective inhibitor of fungal cytochrome P-450-dependent enzyme lanosterol 14-alpha-demethylase has a fungistatic affect .
C. Oropharyngeal candidiasis/ Oesophageal candidiasis